Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (629)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
275
12.980
 Why?
Papillomavirus Infections
19
2025
165
2.930
 Why?
Ovarian Neoplasms
37
2024
449
2.770
 Why?
Endometrial Neoplasms
34
2019
137
2.380
 Why?
Uterine Cervical Dysplasia
16
2017
48
2.370
 Why?
Carcinoma, Squamous Cell
31
2018
326
1.990
 Why?
Gene Expression Regulation, Neoplastic
19
2025
831
1.890
 Why?
Human papillomavirus 16
8
2019
43
1.690
 Why?
Papillomaviridae
17
2025
101
1.590
 Why?
Female
190
2025
27053
1.560
 Why?
Gene Expression Profiling
9
2021
1020
1.520
 Why?
DNA Methylation
22
2025
548
1.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
997
1.280
 Why?
Genital Neoplasms, Female
10
2018
41
1.170
 Why?
Human papillomavirus 18
5
2019
9
1.150
 Why?
Humans
191
2025
50419
1.150
 Why?
Genetic Predisposition to Disease
13
2024
507
1.100
 Why?
Adult
91
2024
13561
1.070
 Why?
Neoplasm Staging
41
2019
738
1.020
 Why?
Middle Aged
98
2024
12579
1.000
 Why?
Adenocarcinoma
18
2018
396
0.990
 Why?
Polymorphism, Single Nucleotide
10
2019
468
0.960
 Why?
MicroRNAs
7
2019
345
0.930
 Why?
Fluorodeoxyglucose F18
15
2022
187
0.930
 Why?
DNA-Binding Proteins
9
2021
410
0.920
 Why?
Neoplasm Recurrence, Local
19
2024
622
0.910
 Why?
Carcinoma
12
2010
137
0.880
 Why?
Oncogene Proteins, Viral
4
2019
52
0.830
 Why?
Radiopharmaceuticals
14
2022
202
0.790
 Why?
Cervix Uteri
7
2017
42
0.780
 Why?
Repressor Proteins
4
2019
149
0.780
 Why?
Alphapapillomavirus
1
2021
13
0.740
 Why?
DNA, Viral
6
2019
134
0.720
 Why?
Cell Line, Tumor
18
2021
1393
0.720
 Why?
Immunologic Factors
2
2014
113
0.700
 Why?
Neoplasm Invasiveness
15
2020
269
0.680
 Why?
Genetic Markers
8
2017
104
0.660
 Why?
Genes, Tumor Suppressor
8
2007
73
0.660
 Why?
Neoplasm Proteins
10
2019
320
0.650
 Why?
Immunoglobulins
3
2017
80
0.640
 Why?
Aged
69
2024
9738
0.640
 Why?
Gene Silencing
5
2018
114
0.610
 Why?
Biomedical Research
1
2022
243
0.610
 Why?
Neoplasms
7
2022
1248
0.600
 Why?
Vascular Endothelial Growth Factor A
2
2017
180
0.540
 Why?
Cisplatin
7
2022
283
0.540
 Why?
Proteomics
1
2019
313
0.530
 Why?
Promoter Regions, Genetic
12
2020
455
0.520
 Why?
HLA-C Antigens
2
2018
5
0.510
 Why?
Receptors, KIR
2
2018
12
0.500
 Why?
Genomics
3
2018
238
0.500
 Why?
Aged, 80 and over
35
2024
3233
0.500
 Why?
Positron-Emission Tomography
11
2013
290
0.490
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.490
 Why?
Tumor Virus Infections
4
2006
47
0.490
 Why?
Lymph Nodes
10
2010
256
0.480
 Why?
Alleles
6
2025
252
0.480
 Why?
Microsatellite Repeats
14
2007
37
0.480
 Why?
Disease-Free Survival
17
2013
439
0.470
 Why?
Hysterectomy
15
2022
88
0.470
 Why?
Gynecologic Surgical Procedures
4
2010
29
0.470
 Why?
Virus Integration
3
2025
9
0.460
 Why?
Granulosa Cell Tumor
2
2024
2
0.450
 Why?
Phenotype
4
2016
736
0.450
 Why?
Lymphatic Metastasis
14
2019
221
0.430
 Why?
Chromosomes, Human, Pair 6
4
2007
14
0.430
 Why?
Immunohistochemistry
13
2024
955
0.430
 Why?
Nuclear Proteins
8
2009
235
0.420
 Why?
Loss of Heterozygosity
10
2007
75
0.420
 Why?
Prognosis
18
2021
1974
0.420
 Why?
Ovary
2
2008
114
0.400
 Why?
Membrane Proteins
3
2005
337
0.400
 Why?
Genotype
9
2018
525
0.390
 Why?
STAT3 Transcription Factor
3
2021
77
0.390
 Why?
Survival Analysis
14
2021
658
0.390
 Why?
Cell Movement
5
2021
244
0.390
 Why?
Ultrasonic Therapy
3
2001
34
0.380
 Why?
Peritoneal Neoplasms
4
2008
63
0.370
 Why?
Carcinoma, Endometrioid
6
2014
38
0.370
 Why?
Genes, p53
2
2010
49
0.370
 Why?
Cell Proliferation
6
2021
980
0.370
 Why?
Risk Factors
13
2019
3712
0.360
 Why?
Signal Transduction
8
2021
1608
0.360
 Why?
Uterine Neoplasms
5
2009
60
0.350
 Why?
Mutation
12
2018
1275
0.350
 Why?
Antineoplastic Agents
9
2014
1165
0.350
 Why?
Ascites
2
2008
28
0.340
 Why?
Carboplatin
2
2009
54
0.340
 Why?
Antibodies, Monoclonal
5
2021
460
0.340
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.340
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
11
0.340
 Why?
Cohort Studies
13
2024
1451
0.340
 Why?
Base Sequence
8
2019
622
0.330
 Why?
Disease Progression
6
2020
825
0.330
 Why?
Membrane Glycoproteins
2
2009
246
0.330
 Why?
GTPase-Activating Proteins
1
2009
23
0.330
 Why?
DNA, Neoplasm
11
2006
144
0.320
 Why?
Chromosomes, Human, Pair 11
3
2005
49
0.320
 Why?
Matrix Metalloproteinase 9
1
2009
88
0.320
 Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.320
 Why?
Brachytherapy
9
2014
46
0.310
 Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.310
 Why?
Combined Modality Therapy
11
2010
640
0.310
 Why?
Abdominal Neoplasms
1
2009
15
0.310
 Why?
DNA Repair
11
2007
187
0.310
 Why?
Genome, Human
3
2025
108
0.310
 Why?
Retrospective Studies
33
2024
6274
0.310
 Why?
Laser Coagulation
1
2009
26
0.310
 Why?
Drug Administration Schedule
10
2013
373
0.300
 Why?
Homeodomain Proteins
2
2006
79
0.300
 Why?
Deoxycytidine
4
2006
28
0.300
 Why?
RNA-Binding Proteins
2
2021
116
0.290
 Why?
Protozoan Proteins
1
2008
29
0.290
 Why?
Laparoscopy
3
2022
172
0.290
 Why?
Germ-Line Mutation
3
2024
61
0.290
 Why?
Microsatellite Instability
5
2019
19
0.290
 Why?
Kaplan-Meier Estimate
6
2019
462
0.290
 Why?
Drug Resistance, Neoplasm
6
2016
315
0.280
 Why?
Ovariectomy
7
2010
115
0.280
 Why?
Antigens, CD
2
2007
221
0.280
 Why?
Chromosomes, Human, Pair 3
4
2001
18
0.270
 Why?
Polymerase Chain Reaction
9
2010
447
0.270
 Why?
SOXC Transcription Factors
2
2019
13
0.270
 Why?
Heart Arrest
1
2009
153
0.270
 Why?
Receptors, Estrogen
3
2024
132
0.270
 Why?
Topotecan
5
2013
17
0.260
 Why?
POU Domain Factors
1
2006
1
0.260
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
400
0.260
 Why?
Vulvar Neoplasms
5
2002
58
0.250
 Why?
Neoplasm Metastasis
5
2021
230
0.250
 Why?
HeLa Cells
3
2021
257
0.250
 Why?
Registries
6
2010
565
0.250
 Why?
Anemia
3
2020
67
0.250
 Why?
Genome, Viral
2
2025
73
0.250
 Why?
Survival Rate
10
2009
906
0.240
 Why?
Breast Neoplasms
5
2018
1198
0.240
 Why?
Vaginal Smears
6
2006
28
0.240
 Why?
Gene Rearrangement
1
2025
63
0.230
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
568
0.230
 Why?
Chromosome Aberrations
1
2006
279
0.230
 Why?
Young Adult
6
2017
4075
0.230
 Why?
HSP70 Heat-Shock Proteins
1
2004
60
0.220
 Why?
Receptors, Androgen
1
2024
45
0.220
 Why?
Receptors, Progesterone
1
2024
64
0.220
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.220
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.220
 Why?
Oncostatin M
2
2021
5
0.210
 Why?
Quinazolines
1
2003
33
0.210
 Why?
Antigens, Neoplasm
1
2004
148
0.210
 Why?
Genome-Wide Association Study
2
2017
163
0.210
 Why?
Polymorphism, Genetic
5
2018
177
0.210
 Why?
Small Cell Lung Carcinoma
1
2023
28
0.200
 Why?
Omentum
1
2002
15
0.200
 Why?
Case-Control Studies
7
2019
1152
0.200
 Why?
Treatment Outcome
23
2014
5265
0.200
 Why?
Chromosome Deletion
3
2000
134
0.200
 Why?
Proto-Oncogene Proteins c-akt
2
2014
155
0.200
 Why?
Linkage Disequilibrium
3
2017
35
0.200
 Why?
Genetic Variation
4
2019
197
0.190
 Why?
Neoadjuvant Therapy
2
2022
119
0.190
 Why?
Tumor Microenvironment
2
2021
221
0.190
 Why?
Antibodies, Monoclonal, Humanized
5
2013
224
0.190
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.190
 Why?
CA-125 Antigen
3
2008
16
0.190
 Why?
Base Pair Mismatch
5
2006
21
0.190
 Why?
Chemoradiotherapy
1
2022
42
0.190
 Why?
Suction
1
2001
24
0.190
 Why?
Postoperative Complications
3
2022
1030
0.190
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.190
 Why?
Smoking
1
2005
506
0.190
 Why?
Proteins
5
2008
340
0.180
 Why?
Radiotherapy, Conformal
2
2014
53
0.180
 Why?
Carcinoma in Situ
2
2013
73
0.180
 Why?
Colorectal Neoplasms
3
2002
256
0.180
 Why?
Adaptor Proteins, Signal Transducing
8
2007
200
0.180
 Why?
Antimetabolites, Antineoplastic
2
2002
35
0.180
 Why?
Gene Regulatory Networks
2
2019
106
0.180
 Why?
Minority Groups
1
2022
130
0.180
 Why?
Fetofetal Transfusion
1
2020
6
0.180
 Why?
Pregnancy, Twin
1
2020
6
0.180
 Why?
Polycythemia
1
2020
9
0.180
 Why?
Radiotherapy
3
2010
125
0.170
 Why?
Twins, Monozygotic
1
2020
15
0.170
 Why?
Sarcoma
3
2009
65
0.170
 Why?
Lymph Node Excision
7
2019
131
0.170
 Why?
Genetic Diseases, Inborn
1
2000
20
0.170
 Why?
Transcriptome
2
2020
314
0.170
 Why?
Patient Satisfaction
2
2006
276
0.170
 Why?
Receptor, erbB-3
1
2020
1
0.170
 Why?
Furin
1
2020
3
0.170
 Why?
Phosphoproteins
2
2016
116
0.170
 Why?
HLA-DQ Antigens
1
2000
3
0.170
 Why?
Receptor, IGF Type 1
1
2020
21
0.170
 Why?
Tomography, X-Ray Computed
7
2013
1163
0.170
 Why?
Mice, Nude
4
2021
247
0.160
 Why?
Prenatal Diagnosis
1
2020
96
0.160
 Why?
Tumor Cells, Cultured
7
2021
453
0.160
 Why?
RNA, Neoplasm
3
2007
44
0.160
 Why?
Antibodies, Neoplasm
1
2019
28
0.160
 Why?
Students
1
2022
219
0.160
 Why?
Papillomavirus E7 Proteins
2
2017
31
0.160
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
 Why?
Reproducibility of Results
2
2022
1181
0.160
 Why?
Placenta
1
2020
134
0.160
 Why?
Follow-Up Studies
13
2019
2231
0.150
 Why?
Indocyanine Green
1
2019
34
0.150
 Why?
Doxorubicin
4
2009
235
0.150
 Why?
Decision Making
1
2001
271
0.150
 Why?
Fallopian Tube Neoplasms
3
2008
14
0.150
 Why?
Salvage Therapy
3
2008
137
0.150
 Why?
Sequence Analysis, DNA
1
2019
194
0.150
 Why?
Cyclooxygenase 2
2
2017
43
0.150
 Why?
Lung Neoplasms
2
2023
597
0.150
 Why?
Adolescent
12
2017
6453
0.140
 Why?
Transcription Factors
1
2021
561
0.140
 Why?
HLA-DRB1 Chains
1
2017
4
0.140
 Why?
HLA-B Antigens
1
2017
8
0.140
 Why?
Metabolic Networks and Pathways
1
2018
92
0.140
 Why?
DNA Copy Number Variations
1
2018
109
0.140
 Why?
Proto-Oncogene Proteins
5
2004
150
0.140
 Why?
Receptors, Vitronectin
1
1997
1
0.140
 Why?
Tumor Suppressor Proteins
3
2005
127
0.140
 Why?
Carcinoma, Adenosquamous
3
2009
7
0.140
 Why?
DNA Mutational Analysis
9
2005
175
0.140
 Why?
Bayes Theorem
1
2017
105
0.140
 Why?
Interleukin-10
1
2017
84
0.140
 Why?
Adipose Tissue
1
2019
192
0.140
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
17
0.140
 Why?
Animals
10
2021
13063
0.140
 Why?
In Situ Hybridization
3
2008
66
0.140
 Why?
Leukocytes, Mononuclear
1
2017
118
0.140
 Why?
Protein Binding
1
2019
648
0.140
 Why?
Radiotherapy, Intensity-Modulated
2
2009
177
0.130
 Why?
Risk Assessment
9
2019
1268
0.130
 Why?
Gene Expression Regulation, Viral
1
2017
47
0.130
 Why?
Radiotherapy Dosage
8
2014
248
0.130
 Why?
Body Mass Index
3
2010
674
0.130
 Why?
Radiation Injuries
3
2008
112
0.130
 Why?
Carrier Proteins
7
2006
297
0.130
 Why?
ROC Curve
1
2017
223
0.130
 Why?
Diagnosis, Differential
4
2024
1029
0.130
 Why?
Taxoids
3
2006
37
0.130
 Why?
Biopsy
5
2006
588
0.130
 Why?
Prospective Studies
10
2019
2378
0.130
 Why?
Estrogens
1
2017
225
0.120
 Why?
Molecular Sequence Data
5
2009
760
0.120
 Why?
Colposcopy
3
2006
17
0.120
 Why?
Cells, Cultured
2
2017
1563
0.120
 Why?
Mice
6
2021
5659
0.120
 Why?
Carcinosarcoma
3
2019
18
0.120
 Why?
Apoptosis
2
2021
1092
0.120
 Why?
Protein Kinase Inhibitors
2
2014
204
0.120
 Why?
Sensitivity and Specificity
4
2006
855
0.120
 Why?
Double-Blind Method
1
2017
710
0.120
 Why?
Algorithms
1
2019
624
0.120
 Why?
Ultrasonography, Doppler, Color
1
1995
31
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1369
0.120
 Why?
Aneurysm
1
1995
33
0.120
 Why?
Obesity
5
2010
1123
0.120
 Why?
Phosphatidylinositol 3-Kinases
2
2014
139
0.120
 Why?
DNA Primers
2
2006
205
0.120
 Why?
Platinum Compounds
4
2008
11
0.120
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.110
 Why?
Cyclohexanones
1
2014
5
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
 Why?
Embolization, Therapeutic
1
1995
87
0.110
 Why?
Transcriptional Activation
2
2019
120
0.110
 Why?
TOR Serine-Threonine Kinases
1
2014
76
0.110
 Why?
Camptothecin
3
2010
15
0.110
 Why?
Genetic Association Studies
1
2014
118
0.110
 Why?
Paclitaxel
4
2007
84
0.110
 Why?
Introns
1
2013
49
0.110
 Why?
Hypercalcemia
1
1993
33
0.110
 Why?
Decision Support Techniques
2
2010
70
0.110
 Why?
Chromosome Mapping
3
2005
143
0.100
 Why?
Pyridines
1
2014
130
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
182
0.100
 Why?
Brain Neoplasms
1
2016
281
0.100
 Why?
Keratinocytes
2
2006
73
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
35
0.100
 Why?
Models, Genetic
1
2012
166
0.100
 Why?
Tomography, Emission-Computed
4
2005
53
0.100
 Why?
Groin
2
2002
16
0.100
 Why?
RNA, Messenger
4
2021
1085
0.100
 Why?
Glucose
1
2014
340
0.090
 Why?
Laser Therapy
1
1992
83
0.090
 Why?
Cystadenocarcinoma, Serous
2
2024
71
0.090
 Why?
Exons
3
2007
94
0.090
 Why?
Pyrazoles
2
2023
111
0.090
 Why?
Infusions, Intravenous
4
2006
212
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1546
0.090
 Why?
Heterozygote
2
2004
83
0.090
 Why?
Wound Healing
1
1992
183
0.090
 Why?
Condylomata Acuminata
1
1991
4
0.090
 Why?
Models, Statistical
1
2012
224
0.090
 Why?
Epithelium
2
2007
66
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
19
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Predictive Value of Tests
6
2010
924
0.090
 Why?
Leiomyoma
1
1990
24
0.090
 Why?
Cell Differentiation
2
2009
640
0.090
 Why?
Epigenesis, Genetic
2
2019
371
0.080
 Why?
Polymorphism, Restriction Fragment Length
1
2010
59
0.080
 Why?
Restriction Mapping
3
2006
33
0.080
 Why?
Colonic Neoplasms
2
2004
156
0.080
 Why?
Gastrointestinal Hemorrhage
1
1990
80
0.080
 Why?
Skin Transplantation
1
1990
43
0.080
 Why?
Down-Regulation
4
2020
338
0.080
 Why?
Age Factors
4
2006
1118
0.080
 Why?
Fluorouracil
2
2006
59
0.080
 Why?
Maximum Tolerated Dose
5
2010
39
0.080
 Why?
Endometrium
3
2019
40
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.080
 Why?
Intestinal Diseases
1
2009
26
0.080
 Why?
Transcription, Genetic
4
2019
354
0.080
 Why?
Lasers, Gas
1
2009
7
0.080
 Why?
Embolism, Air
1
2009
12
0.080
 Why?
Lymphatic Vessels
1
2009
53
0.080
 Why?
Vaginal Neoplasms
2
2005
4
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
 Why?
Fluorine Radioisotopes
1
2008
24
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
5
0.080
 Why?
Infertility, Female
1
2008
18
0.080
 Why?
Polyethylene Glycols
2
2006
84
0.070
 Why?
Haplotypes
2
2017
83
0.070
 Why?
Eimeria
1
2008
3
0.070
 Why?
Up-Regulation
2
2020
446
0.070
 Why?
Ubiquitin
1
2008
45
0.070
 Why?
Cell Cycle Proteins
1
2009
163
0.070
 Why?
Angiogenesis Inhibitors
2
2006
183
0.070
 Why?
Cricetinae
1
2008
207
0.070
 Why?
Tumor Burden
2
2021
130
0.070
 Why?
Expressed Sequence Tags
1
2007
8
0.070
 Why?
Infusion Pumps
1
1987
13
0.070
 Why?
Fluorescent Antibody Technique
1
2007
109
0.070
 Why?
Diagnostic Imaging
1
2009
182
0.070
 Why?
Microdissection
1
2007
18
0.070
 Why?
Models, Biological
2
2008
717
0.070
 Why?
Precancerous Conditions
2
2005
83
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Aorta
3
2005
159
0.070
 Why?
Stromal Cells
1
2007
75
0.070
 Why?
Organ Specificity
2
2018
109
0.070
 Why?
Lasers
1
2007
106
0.070
 Why?
Codon
2
2003
37
0.070
 Why?
Pelvic Floor
1
2007
51
0.070
 Why?
RNA, Double-Stranded
1
2006
14
0.070
 Why?
Recombinant Proteins
1
2008
477
0.070
 Why?
Neutropenia
1
2007
116
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.070
 Why?
Tissue Fixation
1
2006
35
0.070
 Why?
Intestinal Perforation
2
2006
23
0.060
 Why?
Specimen Handling
1
2006
55
0.060
 Why?
Pulmonary Embolism
1
1987
99
0.060
 Why?
Protein Kinases
1
2006
68
0.060
 Why?
Head and Neck Neoplasms
2
2016
288
0.060
 Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
 Why?
Proportional Hazards Models
4
2010
416
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Abdomen
1
2006
75
0.060
 Why?
Papillomavirus Vaccines
1
2006
66
0.060
 Why?
Recurrence
4
2010
657
0.060
 Why?
Neovascularization, Pathologic
1
2006
155
0.060
 Why?
Probability
4
2007
163
0.060
 Why?
Terminal Care
1
2005
46
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
51
0.060
 Why?
Cell Adhesion Molecules
1
2005
86
0.060
 Why?
Quinolines
1
2004
42
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
212
0.060
 Why?
Amyloid
1
2004
24
0.060
 Why?
Tissue Distribution
1
2004
167
0.060
 Why?
Genes, Viral
1
2003
38
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
227
0.050
 Why?
Lactones
1
2003
26
0.050
 Why?
Abdomen, Acute
1
2003
6
0.050
 Why?
RNA, Viral
2
2016
107
0.050
 Why?
Biopsy, Needle
4
2006
179
0.050
 Why?
Thrombospondins
1
2003
8
0.050
 Why?
Obesity, Morbid
1
2004
78
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.050
 Why?
Pyrimidinones
1
2023
19
0.050
 Why?
Clinical Competence
1
2006
403
0.050
 Why?
Fibroma
1
2003
39
0.050
 Why?
Neoplasms, Second Primary
1
2004
74
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
63
0.050
 Why?
Uterine Hemorrhage
1
2002
8
0.050
 Why?
Congenital Abnormalities
1
2004
113
0.050
 Why?
Age of Onset
2
2004
109
0.050
 Why?
PTEN Phosphohydrolase
2
2019
53
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
326
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
DNA, Ribosomal
1
2002
26
0.050
 Why?
Pregnancy
3
2020
2444
0.050
 Why?
Blood Transfusion, Autologous
1
2002
6
0.050
 Why?
Genital Diseases, Female
1
2002
17
0.050
 Why?
Blood Donors
1
2002
21
0.050
 Why?
Male
10
2016
25866
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Medical History Taking
1
2002
48
0.050
 Why?
Medical Records
1
2002
85
0.050
 Why?
Complementary Therapies
1
2002
26
0.050
 Why?
Family Health
1
2002
76
0.050
 Why?
AU Rich Elements
1
2021
1
0.050
 Why?
Postmenopause
1
2002
96
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
5
0.050
 Why?
RNA Stability
1
2021
22
0.050
 Why?
Cytokine Receptor gp130
1
2021
13
0.050
 Why?
3' Untranslated Regions
1
2021
52
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
109
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
22
0.040
 Why?
Blotting, Southern
3
2002
41
0.040
 Why?
Internship and Residency
1
2006
443
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
210
0.040
 Why?
Catheterization, Central Venous
1
2001
84
0.040
 Why?
Phosphoric Monoester Hydrolases
1
2000
20
0.040
 Why?
Equipment Design
1
2001
290
0.040
 Why?
Blood Vessels
1
2001
71
0.040
 Why?
Uganda
1
2020
35
0.040
 Why?
Logistic Models
2
2017
901
0.040
 Why?
Isoenzymes
1
2001
165
0.040
 Why?
Quality Improvement
1
2022
215
0.040
 Why?
Risk Management
1
2000
31
0.040
 Why?
Incidence
3
2007
1027
0.040
 Why?
Physical Chromosome Mapping
1
2000
8
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Patient Discharge
1
2022
318
0.040
 Why?
Interviews as Topic
1
2001
275
0.040
 Why?
Cell Survival
1
2021
587
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
 Why?
DNA Repair Enzymes
1
1999
42
0.040
 Why?
Adenosine Triphosphatases
1
1999
88
0.040
 Why?
Cell Nucleus
1
2019
183
0.040
 Why?
Regression Analysis
3
2006
376
0.040
 Why?
Pregnancy Outcome
1
2020
205
0.040
 Why?
Cross-Sectional Studies
1
2024
1601
0.040
 Why?
Molecular Targeted Therapy
1
2019
122
0.040
 Why?
Coloring Agents
1
2019
67
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Gene Dosage
1
2018
73
0.040
 Why?
Histone Demethylases
1
2018
17
0.040
 Why?
Leptin
1
2019
142
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
51
0.040
 Why?
Databases, Genetic
1
2018
77
0.040
 Why?
Estradiol
1
2019
221
0.040
 Why?
Major Histocompatibility Complex
1
2017
12
0.040
 Why?
Genotyping Techniques
1
2017
19
0.040
 Why?
Mass Screening
1
2000
343
0.030
 Why?
Chemokines
1
2017
75
0.030
 Why?
Time Factors
4
2010
2933
0.030
 Why?
Receptors, Collagen
1
1997
3
0.030
 Why?
Receptors, Fibronectin
1
1997
5
0.030
 Why?
Coculture Techniques
1
2017
140
0.030
 Why?
Integrins
1
1997
29
0.030
 Why?
Chemotherapy, Adjuvant
2
2010
119
0.030
 Why?
Diet, High-Fat
1
2019
214
0.030
 Why?
Quality-Adjusted Life Years
2
2010
62
0.030
 Why?
Epithelial Cells
2
2006
203
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
732
0.030
 Why?
Herpesviridae
1
2016
17
0.030
 Why?
Viruses
1
2016
21
0.030
 Why?
Host-Pathogen Interactions
1
2017
134
0.030
 Why?
Mice, Transgenic
1
2017
537
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
40
0.030
 Why?
DNA Replication
1
1997
155
0.030
 Why?
Cost-Benefit Analysis
2
2010
263
0.030
 Why?
Plasmids
2
2001
159
0.030
 Why?
Sequence Analysis, RNA
1
2016
87
0.030
 Why?
Central Nervous System Neoplasms
1
2016
61
0.030
 Why?
Fibroblasts
1
2017
338
0.030
 Why?
Electrosurgery
1
1995
8
0.030
 Why?
Prostatic Neoplasms
1
1998
386
0.030
 Why?
CpG Islands
2
2008
107
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Computational Biology
1
2016
194
0.030
 Why?
Arteries
1
1995
91
0.030
 Why?
Cytokines
1
2017
602
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Multivariate Analysis
2
2009
583
0.030
 Why?
Treatment Failure
2
2008
120
0.030
 Why?
Missouri
2
2006
63
0.030
 Why?
Organs at Risk
1
2014
71
0.030
 Why?
Inclusion Bodies
1
1993
18
0.030
 Why?
Cell Division
2
1994
292
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
22
0.030
 Why?
Cell Death
1
2014
175
0.030
 Why?
Imaging, Three-Dimensional
1
2014
151
0.030
 Why?
Risk
2
2004
325
0.030
 Why?
Skin Physiological Phenomena
1
1992
12
0.030
 Why?
Epidermis
1
1992
23
0.030
 Why?
Guinea Pigs
1
1992
75
0.030
 Why?
Pelvis
2
2004
66
0.020
 Why?
Regeneration
1
1992
58
0.020
 Why?
Pedigree
2
2004
119
0.020
 Why?
Deoxyglucose
1
2012
36
0.020
 Why?
Colectomy
1
1992
35
0.020
 Why?
Computer Simulation
1
2012
273
0.020
 Why?
Pilot Projects
2
2004
694
0.020
 Why?
Sequence Deletion
2
2003
66
0.020
 Why?
Premenopause
1
2010
26
0.020
 Why?
Amino Acid Sequence
2
2003
575
0.020
 Why?
Staurosporine
1
2010
12
0.020
 Why?
Anastomosis, Surgical
1
1990
65
0.020
 Why?
Remission Induction
1
2010
208
0.020
 Why?
Molecular Weight
1
1990
82
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
67
0.020
 Why?
ras Proteins
2
2001
65
0.020
 Why?
Cicatrix
1
1990
39
0.020
 Why?
Staining and Labeling
1
1990
97
0.020
 Why?
Hemoglobins
1
1990
112
0.020
 Why?
Chi-Square Distribution
1
2010
275
0.020
 Why?
Child
3
2006
6931
0.020
 Why?
Perioperative Care
1
2009
42
0.020
 Why?
Fetus
1
1990
184
0.020
 Why?
Urinary Incontinence
1
2009
38
0.020
 Why?
Gene Knockdown Techniques
1
2009
104
0.020
 Why?
Organoplatinum Compounds
1
2008
14
0.020
 Why?
Vinblastine
1
2008
22
0.020
 Why?
Life Style
1
2009
145
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
183
0.020
 Why?
Emotions
1
2009
167
0.020
 Why?
Cell Line
1
1990
997
0.020
 Why?
Skin
1
1990
382
0.020
 Why?
Cadherins
1
2007
61
0.020
 Why?
Demography
1
2007
93
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
134
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
DNA Mismatch Repair
1
2006
16
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
13
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
NIH 3T3 Cells
1
2006
51
0.020
 Why?
Immunoenzyme Techniques
2
2001
140
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
12
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
161
0.020
 Why?
Cryopreservation
1
2006
33
0.020
 Why?
Analysis of Variance
1
2007
549
0.020
 Why?
Transfection
1
2006
353
0.020
 Why?
Gene Expression
1
2008
605
0.020
 Why?
Mutation, Missense
1
2006
103
0.020
 Why?
Nurse Practitioners
1
2006
42
0.020
 Why?
Gynecology
1
2006
48
0.020
 Why?
Early Diagnosis
1
2006
87
0.020
 Why?
Medical Futility
1
2005
8
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Cyclophosphamide
1
2006
168
0.020
 Why?
Triage
1
2006
60
0.020
 Why?
Leiomyosarcoma
1
2005
20
0.020
 Why?
Hospice Care
1
2005
27
0.010
 Why?
Cytodiagnosis
1
2005
41
0.010
 Why?
Health Services
1
2005
65
0.010
 Why?
Phosphorylation
1
2006
520
0.010
 Why?
Obstetrics
1
2006
85
0.010
 Why?
Lymphatic System
1
2004
13
0.010
 Why?
Penetrance
1
2004
6
0.010
 Why?
Area Under Curve
1
2004
179
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
73
0.010
 Why?
Calcification, Physiologic
1
2004
40
0.010
 Why?
Laparotomy
1
2004
35
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Ethanol
1
2006
336
0.010
 Why?
Macrolides
1
2003
16
0.010
 Why?
Genomic Instability
1
2004
90
0.010
 Why?
Tamoxifen
1
2004
61
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Genes, p16
1
2003
8
0.010
 Why?
Confidence Intervals
1
2003
155
0.010
 Why?
Codon, Terminator
1
2003
5
0.010
 Why?
Administration, Oral
1
2004
438
0.010
 Why?
Frameshift Mutation
1
2003
16
0.010
 Why?
Liposomes
1
2003
52
0.010
 Why?
Mutagenesis, Insertional
1
2003
21
0.010
 Why?
Palliative Care
1
2005
191
0.010
 Why?
Body Weight
1
2005
517
0.010
 Why?
Cytoskeletal Proteins
1
2003
47
0.010
 Why?
DNA Transposable Elements
1
2003
101
0.010
 Why?
Physicians
1
2006
235
0.010
 Why?
Prevalence
1
2006
967
0.010
 Why?
Reference Values
1
2003
302
0.010
 Why?
beta Catenin
1
2003
96
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
19
0.010
 Why?
Ifosfamide
1
2002
11
0.010
 Why?
Documentation
1
2002
32
0.010
 Why?
Trans-Activators
1
2003
135
0.010
 Why?
Bleomycin
1
2002
34
0.010
 Why?
Hospitals, University
1
2002
75
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
73
0.010
 Why?
Equipment Failure
1
2001
63
0.010
 Why?
Age Distribution
1
2002
172
0.010
 Why?
Statistics, Nonparametric
1
2002
189
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
77
0.010
 Why?
Nucleic Acid Hybridization
2
1991
56
0.010
 Why?
Carcinoma, Small Cell
1
2001
25
0.010
 Why?
Genes, erbB-1
1
2001
8
0.010
 Why?
Radiography
1
2002
482
0.010
 Why?
Outpatients
1
2002
121
0.010
 Why?
Hospitalization
1
2005
677
0.010
 Why?
DNA
1
2004
534
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
89
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
154
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
21
0.010
 Why?
Morbidity
1
2000
130
0.010
 Why?
Blotting, Western
1
2001
575
0.010
 Why?
Gene Deletion
1
2000
260
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
153
0.010
 Why?
Chromosomes, Bacterial
1
1998
5
0.010
 Why?
Cloning, Molecular
1
1998
190
0.010
 Why?
Infant
1
2006
3648
0.010
 Why?
Child, Preschool
1
2006
3953
0.010
 Why?
Drug Resistance, Multiple
1
1997
24
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
66
0.010
 Why?
Gene Frequency
1
1997
93
0.010
 Why?
United States
1
2007
5005
0.010
 Why?
Dimethyl Sulfoxide
1
1994
13
0.010
 Why?
Glycerol
1
1994
15
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
54
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
129
0.010
 Why?
Drug Carriers
1
1994
69
0.010
 Why?
Cell Cycle
1
1994
227
0.010
 Why?
Retroperitoneal Space
1
1991
27
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (629) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department